Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Alcon prepares carbonic anhydrase inhibitors

March 13, 1997

Positive phase I results for new formulation of lexipafant

March 12, 1997

Gene linked to juvenile macular degeneration cloned

March 7, 1997

Nonsurgical treatment for vitreous hemorrhage enters clinic in the U.S.

March 6, 1997

Medarex acquires Houston Biotechnology

March 5, 1997

Dorzolamide and timolol alone and in combination for glaucoma

March 4, 1997

AEterna codevelopment agreement for AE-941

Feb. 27, 1997

Bio-Technology General grants license to BioLon in Japan

Feb. 26, 1997

Comparative trial of dorzolamide and acetazolamide

Feb. 21, 1997

Alcon describes dihydropyridines for ocular use

Feb. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...